SCHEMBL17309448

SCHEMBL17309448

CCCN1C(=O)/C(=C/c2ccc(N(C)C)cc2)S/C1=N/c1ccccc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FAAH O00519 2/20 1.00
▸ LMNA P02545 2/20 0.72
▸ HPGD P15428 1/20 0.72
▸ SMN1; SMN2 Q16637 1/20 0.72
▸ CA9 Q16790 7/20 0.71
▸ ITGB3 P05106 1/20 0.65
▸ ITGAV P06756 1/20 0.65
▸ PPARA Q07869 1/20 0.55
▸ MGAM O43451 1/20 0.54
▸ CA12 O43570 1/20 0.54
▸ CA1 P00915 1/20 0.54
▸ CA2 P00918 1/20 0.54
▸ MAOA P21397 1/20 0.54
▸ MAOB P27338 1/20 0.54
▸ S1PR1 P21453 1/20 0.53
▸ S1PR3 Q99500 1/20 0.53
▸ MEN1 O00255 1/20 0.53
▸ MAPT P10636 1/20 0.53
▸ RAB9A P51151 1/20 0.53
▸ KMT2A Q03164 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19481521 1.00 FAAH (1.00) FAAHLMNAHPGDSMN1; SMN2CA9
SCHEMBL19481507 0.84 FAAH (0.73) FAAHLMNAHPGDSMN1; SMN2CA9
SCHEMBL17295612 0.84 LMNA (0.75) FAAHLMNAHPGDSMN1; SMN2CA9
SCHEMBL17295616 0.84 LMNA (0.75) FAAHLMNAHPGDSMN1; SMN2CA9
SCHEMBL27861589 0.83 FAAH (0.70) FAAHLMNAHPGDSMN1; SMN2CA9
SCHEMBL11333427 0.82 LMNA (0.72) FAAHLMNAHPGDSMN1; SMN2CA9
SCHEMBL11333429 0.82 LMNA (0.72) FAAHLMNAHPGDSMN1; SMN2CA9
SCHEMBL28686336 0.81 FAAH (0.68) FAAHLMNAHPGDSMN1; SMN2CA9
SCHEMBL11329893 0.81 CA9 (0.77) FAAHLMNAHPGDSMN1; SMN2CA9
SCHEMBL11329898 0.81 CA9 (0.77) FAAHLMNAHPGDSMN1; SMN2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3148541-B1 THIAZOLIDINONES AS CELLULAR ANANDAMIDE UPTAKE INHIBITORS AND THEIR USE IN THE TREATMENT OF PSYCHIATRIC OR NEUROLOGICAL DISORDERS AND INFLAMMATION, IN PARTICULAR NEUROINFLAMMATION UNIV BERN (CH) 2020-09-02 — — EP disclosed
EP-2952188-A1 Thiazolidinones as cellular anandamide uptake inhibitors and their use in the treatment of psychiatric or neurological disorders and inflammation, in particular neuroinflammation Universität Bern (CH) 2015-12-09 — — EP disclosed
WO-2015181336-A1 THIAZOLIDINONES AS CELLULAR ANANDAMIDE UPTAKE INHIBITORS AND THEIR USE IN THE TREATMENT OF PSYCHIATRIC OR NEUROLOGICAL DISORDERS AND INFLAMMATION, IN PARTICULAR NEUROINFLAMMATION Universität Bern (CH) 2015-12-03 — — WO disclosed
Send feedback